Novartis AG logo

Novartis AG - Cedear

NEW
BUE:NVS (Switzerland)   Cedear
ARS 54,900 -8,600 (-13.54%) Sep 8
21.21
P/B:
6.40
Market Cap:
ARS 397.08T ($ 262.32B)
Enterprise V:
ARS 460.16T ($ 303.99B)
Volume:
6.46K
Avg Vol (2M):
464.00
Trade In:
Volume:
6.46K
Avg Vol (2M):
464.00

Novartis AG’s share price is ARS54900. Its GF Value is ARS52184.46. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Novartis AG stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: ARS54900 GF Value Price/GF Value
Current ARS52184.46 1.05
Next FY1 End ARS53161.66 1.03
Next 12 Month ARS55715.15 0.99
Next FY2 End ARS56574.5 0.97
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Novartis AG's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Novartis AG's stock price and Revenue per share, with a coefficient of 96%. This is followed by a 96% correlation with Book Value per share and a 94% correlation with Operating Cash Flow per share. The weakest correlation is observed with Operating Cash Flow per share, at 94%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies